{"retracted":false,"update":{"timestamp":1480550400000,"doi":"10.1016/j.neo.2016.10.005","type":"erratum"},"doi":"10.1016/j.neo.2016.02.005","journal":"Neoplasia","publisher":"Elsevier BV","title":"Corrigendum to “A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells” [Neoplasia 18 (2016) 199-212]"}
